Matching
Unviariate Logistic regression cohort 913
hosp_outcome_30days_status
Characteristic |
N |
OR |
95% CI |
p-value |
year_10 |
913 |
1.18 |
1.0, 1.42 |
0.064 |
Gender_Legal_Sex |
913 |
|
|
|
Female |
|
— |
— |
|
Male |
|
1.01 |
0.65, 1.58 |
0.953 |
vaccine_ACTUAL |
913 |
|
|
|
0 |
|
— |
— |
|
1 |
|
0.66 |
0.40, 1.12 |
0.112 |
htn |
913 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.40 |
0.78, 2.70 |
0.283 |
dm |
913 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.34 |
0.86, 2.10 |
0.192 |
cad |
913 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.39 |
0.89, 2.19 |
0.144 |
copd |
913 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.51 |
0.86, 2.55 |
0.136 |
renal_group2 |
913 |
|
|
|
eGFR 45-59.9, no ESKD |
|
— |
— |
|
ESKD |
|
1.64 |
0.80, 3.14 |
0.155 |
eGFR 30-44.9, no ESKD |
|
1.34 |
0.77, 2.28 |
0.287 |
eGFR <30, no ESKD |
|
1.88 |
0.86, 3.80 |
0.094 |
immunosuppressant |
913 |
|
|
|
0 |
|
— |
— |
|
1 |
|
2.16 |
0.91, 4.58 |
0.059 |
Multvariate logistic regression cohort 913
hosp_outcome_30days_status
Characteristic |
N |
OR |
95% CI |
p-value |
year_10 |
913 |
1.20 |
1.0, 1.45 |
0.063 |
Gender_Legal_Sex |
913 |
|
|
|
Female |
|
— |
— |
|
Male |
|
0.94 |
0.60, 1.49 |
0.806 |
vaccine_ACTUAL |
913 |
|
|
|
0 |
|
— |
— |
|
1 |
|
0.53 |
0.31, 0.93 |
0.023 |
htn |
913 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.23 |
0.62, 2.57 |
0.570 |
dm |
913 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.16 |
0.72, 1.89 |
0.538 |
cad |
913 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.19 |
0.72, 1.98 |
0.491 |
copd |
913 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.36 |
0.75, 2.37 |
0.287 |
renal_group2 |
913 |
|
|
|
eGFR 45-59.9, no ESKD |
|
— |
— |
|
ESKD |
|
1.68 |
0.79, 3.36 |
0.157 |
eGFR 30-44.9, no ESKD |
|
1.19 |
0.67, 2.05 |
0.541 |
eGFR <30, no ESKD |
|
1.69 |
0.76, 3.47 |
0.171 |
immunosuppressant |
913 |
|
|
|
0 |
|
— |
— |
|
1 |
|
2.19 |
0.90, 4.77 |
0.061 |
Multivariate cohort 913 hosp_outcome_30days_status plot
Unviariate Logistic regression cohort 913 death_status_30
Characteristic |
N |
OR |
95% CI |
p-value |
age_bl |
913 |
1.05 |
1.01, 1.09 |
0.010 |
vaccine_ACTUAL |
913 |
|
|
|
0 |
|
— |
— |
|
1 |
|
0.17 |
0.08, 0.38 |
<0.001 |
Gender_Legal_Sex |
913 |
|
|
|
Female |
|
— |
— |
|
Male |
|
1.60 |
0.72, 3.57 |
0.248 |
htn |
913 |
|
|
|
0 |
|
— |
— |
|
1 |
|
0.44 |
0.19, 1.00 |
0.050 |
dm |
913 |
|
|
|
0 |
|
— |
— |
|
1 |
|
0.42 |
0.17, 1.01 |
0.052 |
cad |
913 |
|
|
|
0 |
|
— |
— |
|
1 |
|
0.89 |
0.41, 1.96 |
0.780 |
copd |
913 |
|
|
|
0 |
|
— |
— |
|
1 |
|
2.85 |
1.24, 6.52 |
0.013 |
renal_group2 |
913 |
|
|
|
eGFR 45-59.9, no ESKD |
|
— |
— |
|
ESKD |
|
1.89 |
0.50, 7.11 |
0.347 |
eGFR 30-44.9, no ESKD |
|
2.93 |
1.17, 7.31 |
0.021 |
eGFR <30, no ESKD |
|
3.50 |
1.05, 11.7 |
0.042 |
Multvariate logistic regression cohort 913 death_status_30
Characteristic |
N |
OR |
95% CI |
p-value |
year_10 |
913 |
1.68 |
1.14, 2.47 |
0.008 |
Gender_Legal_Sex |
913 |
|
|
|
Female |
|
— |
— |
|
Male |
|
1.62 |
0.69, 3.80 |
0.273 |
vaccine_ACTUAL |
913 |
|
|
|
0 |
|
— |
— |
|
1 |
|
0.13 |
0.05, 0.33 |
<0.001 |
htn |
913 |
|
|
|
0 |
|
— |
— |
|
1 |
|
0.59 |
0.19, 1.80 |
0.355 |
dm |
913 |
|
|
|
0 |
|
— |
— |
|
1 |
|
0.38 |
0.14, 1.03 |
0.058 |
cad |
913 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.14 |
0.42, 3.07 |
0.792 |
copd |
913 |
|
|
|
0 |
|
— |
— |
|
1 |
|
4.75 |
1.80, 12.5 |
0.002 |
renal_group2 |
913 |
|
|
|
eGFR 45-59.9, no ESKD |
|
— |
— |
|
ESKD |
|
4.63 |
1.09, 19.7 |
0.038 |
eGFR 30-44.9, no ESKD |
|
2.31 |
0.86, 6.20 |
0.096 |
eGFR <30, no ESKD |
|
2.14 |
0.57, 8.04 |
0.258 |
Multivariate cohort 913 death_status_30 plot
Kaplan Meier 365 days 2 groups

Kaplan Meier 365 days 3 groups

Renal cause specific harzard function relative effects in cohort
without ESKD
Characteristic |
N |
HR |
95% CI |
p-value |
vaccine_ACTUAL |
506 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.03 |
0.39, 2.70 |
0.955 |
cmp_time_new_cv specific harzard function relative effects
Characteristic |
N |
HR |
95% CI |
p-value |
vaccine_ACTUAL |
130 |
|
|
|
0 |
|
— |
— |
|
1 |
|
0.40 |
0.21, 0.75 |
0.005 |
#Time to death 1 year coxph model
Characteristic |
N |
HR |
95% CI |
p-value |
vaccine_ACTUAL |
562 |
|
|
|
0 |
|
— |
— |
|
1 |
|
0.43 |
0.22, 0.84 |
0.013 |